0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Tuberculosis
 161-180 of 327 Articles
JAMA Internal Medicine | 
Original Investigation |  FREE
Susan A. Maloney, MD, MHSc; Katherine L. Fielding, PhD; Kayla F. Laserson, ScD; et al.
Arch Intern Med. 2006;166(2):234-240. doi:10.1001/archinte.166.2.234.

JAMA Pediatrics | 
The Pediatric Forum | 
Kari M. Jacono, MD; Mary Ann O’Riordan, MS; Lydia Furman, MD
Arch Pediatr Adolesc Med. 2006;160(1):106. doi:10.1001/archpedi.160.1.106-a.

JAMA | 
From the Centers for Disease Control and Prevention |  FREE
JAMA. 2005;294(14):1753-1755. doi:10.1001/jama.294.14.1753.

JAMA | 
The Worldin Medicine | 
Joan Stephenson, PhD
JAMA. 2005;294(11):1331. doi:10.1001/jama.294.11.1331-c.

JAMA Internal Medicine | 
Editor's Correspondence | 
Bruce Y. Lee, MD, MBA; Esther H. Chen, MD
Arch Intern Med. 2005;165(15):1794. doi:10.1001/archinte.165.15.1794-a.

JAMA Internal Medicine | 
Editor's Correspondence | 
Juan P. Wisnivesky, MD, MPH; Thomas G. McGinn, MD, MPH
Arch Intern Med. 2005;165(15):1795. doi:10.1001/archinte.165.15.1795-a.

JAMA | 
Brief Report |  FREE
Maryam B. Haddad, MSN, MPH, FNP; Todd W. Wilson, MS, CHES; Kashef Ijaz, MD, MPH; et al.
JAMA. 2005;293(22):2762-2766. doi:10.1001/jama.293.22.2762.

JAMA | 
Commentary | 
Mary D. Nettleman, MD, MS
JAMA. 2005;293(22):2788-2790. doi:10.1001/jama.293.22.2788.

JAMA | 
Commentary | 
Christopher C. Whalen, MD, MS
JAMA. 2005;293(22):2785-2787. doi:10.1001/jama.293.22.2785.

JAMA | 
Commentary | 
Philip C. Hopewell, MD; Madhukar Pai, MD, PhD
JAMA. 2005;293(22):2790-2793. doi:10.1001/jama.293.22.2790.

JAMA | 
Editorial | 
Catherine D. DeAngelis, MD, MPH; Annette Flanagin, RN, MA
JAMA. 2005;293(22):2793-2794. doi:10.1001/jama.293.22.2793.

JAMA | 
Medical News and Perspectives | 
M. J. Friedrich
JAMA. 2005;293(22):2703-2705. doi:10.1001/jama.293.22.2703.

JAMA | 
Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2005;293(22):2705-2707. doi:10.1001/jama.293.22.2705.

JAMA | 
Medical News and Perspectives | 
Mike Mitka
JAMA. 2005;293(22):2707. doi:10.1001/jama.293.22.2707.

JAMA | 
Medical News and Perspectives | 
Mike Mitka
JAMA. 2005;293(22):2708. doi:10.1001/jama.293.22.2708.

JAMA | 
Original Contribution |  FREE
Madhukar Pai, MD, PhD; Kaustubh Gokhale, MD; Rajnish Joshi, MD; et al.
JAMA. 2005;293(22):2746-2755. doi:10.1001/jama.293.22.2746.

JAMA | 
Original Contribution |  FREE
Reuben M. Granich, MD, MPH; Peter Oh, MPH; Bryan Lewis, MPH; et al.
JAMA. 2005;293(22):2732-2739. doi:10.1001/jama.293.22.2732.

JAMA | 
Original Contribution |  FREE
Francis Drobniewski, MD, PhD; Yanina Balabanova, MD, PhD; Vladyslav Nikolayevsky, PhD; et al.
JAMA. 2005;293(22):2726-2731. doi:10.1001/jama.293.22.2726.

JAMA | 
Original Contribution |  FREE
Elvin Geng, MD, MPH; Barry Kreiswirth, PhD; Joe Burzynski, MD, MPH; et al.
JAMA. 2005;293(22):2740-2745. doi:10.1001/jama.293.22.2740.

JAMA | 
Original Contribution |  FREE
Young Ae Kang, MD; Hye Won Lee, MSc; Ho Il Yoon, MD; et al.
JAMA. 2005;293(22):2756-2761. doi:10.1001/jama.293.22.2756.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Notable Notes  | 
The Multifarious Adirondack Chair
Megan E. MacGillivray, MD(C)
JAMA Pediatrics
Editorial  | 
Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents
Ben J. Marais, PhD
JAMA Pediatrics
Original Investigation  | 
Treatment for Preventing Tuberculosis in Children and Adolescents:  A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.
JAMA
Clinical Trials Update  | 
TB Regimens: Less Is Not More
Anita Slomski, MA